- Like, Share, or Comment:
Blog/Industry News
Category Archives: FDA
CMS Finalizes Transitional Coverage for Emerging Technologies (TCET) Pathway: A New...
By: Christopher A. Parrella, Esq., CPC, CHC, CPCO Parrella Health Law, Boston, Ma. A Health Law Defense and Compliance Firm CMS has announced the finalization of its Transitional Coverage for Emerging Technologies (TCET) ...
Read More ›
Court Rejects Former Relator’s Recovery Attempt for Share of Amgen Whistleblower...
By: Christopher A. Parrella, Esq., CPC, CHC, CPCO Parrella Health Law, Boston, Ma. A Health Law Defense and Compliance Firm The False Claims Act (FCA) is an essential weapon in combating fraud against the government, but ...
Read More ›
Boston’s Magellan Diagnostics Pleads Guilty to Criminal Charges Over Faulty Testing...
By: Christopher A. Parrella, Esq., CPC, CHC, CPCO Parrella Health Law, Boston, Ma. A Health Law Defense and Compliance Firm Magellan Diagnostics, a Massachusetts-based medical device company, has pleaded guilty to criminal...
Read More ›
Supreme Court Decision Limits Regulatory Authority: Implications for Healthcare Providers
By: Christopher A. Parrella, Esq., CPC, CHC, CPCO Parrella Health Law, Boston, Ma. A Health Law Defense and Compliance Firm In a landmark decision, the Supreme Court significantly restricted federal agencies' authority to...
Read More ›
Magellan Diagnostics Settles $42 Million for Concealing Lead Test Malfunction
By: Christopher A. Parrella, Esq., CPC, CHC, CPCO Parrella Health Law, Boston, Ma. A Health Law Defense and Compliance Firm Magellan Diagnostics, Inc., a medical device company based in Billerica, Massachusetts, has agreed to pay $42...
Read More ›